Tetra Bio-Pharma
Tetra Bio-Pharma Inc. is a biopharmaceutical company dedicated to the development of cannabinoid-based medicines. Headquartered in Orleans, Canada, the company is focused on creating prescription drugs for conditions such as chronic pain and cancer-related symptoms. Its clinical pipeline includes several products: SERENITY for cancer cachexia and REBORN for breakthrough pain, both in phase 2 trials, as well as PLENITUDE for advanced cancer pain and PPP003 for painful dry eye and uveitis, currently in phase 1. Additionally, Tetra is developing HCC011 for hepatocellular carcinoma. The company emphasizes the integration of traditional medicinal cannabis use with scientific validation and safety data to meet regulatory standards. Tetra Bio-Pharma has established collaboration agreements with various organizations, including Aphria Inc. and the University of New Brunswick, and has a co-development partnership with Storz & Bickel for fibromyalgia treatment. The company was previously known as GrowPros Cannabis Ventures Inc. before rebranding in September 2016.
Top Stages
6 past transactions
Alpha Blue Ocean
Debt Financing in 2022
Alpha Blue Ocean is dedicated to addressing the complexities of modern capital markets, which are increasingly affected by regulatory and compliance challenges. The founders recognized the need for innovative and customized financial solutions to facilitate smoother interactions between companies and their stakeholders. By fostering relationships built on expertise and collaboration, Alpha Blue Ocean aims to create mutually beneficial outcomes that help business partners achieve their goals and gain deserved recognition. The firm emphasizes thorough due diligence and best practices to deliver sustainable solutions for both investors and portfolio structures. With a comprehensive understanding of various asset classes, Alpha Blue Ocean offers flexibility and strives for consistent risk-adjusted performance, positioning itself as a true partner to the companies and management teams it supports.
Mondias Natural Products
Post in 2020
Mondias Natural Products focuses on the commercialization and development of evidence-based botanical products tailored for the healthcare, bio-agriculture, and organic sectors. Through its Holizen Laboratories division, the company offers a range of oral and topical botanical agents designed to address unmet medical needs. Additionally, Mondias is engaged in the development of specialty fertilizers derived from botanical sources, targeting various applications including household plants, lawns, golf courses, urban gardens, nurseries, and commercial greenhouses. The company collaborates with McGill University's Faculty of Agricultural and Environmental Sciences to enhance its offerings for indoor cannabis cultivation and other agricultural uses.
Panag Pharma
Acquisition in 2019
Panag Pharma Inc. is a biotechnology company based in Halifax, Canada, founded in 2014. It specializes in the development of bio-pharmaceuticals and natural health products that incorporate cannabis and other medicinal plant-based elements. The company focuses on creating innovative cannabinoid-based formulations aimed at treating pain and inflammation. Panag Pharma's product pipeline includes pain relief solutions designed for topical application to the skin, eyes, and mucous membranes, emphasizing safety, non-addictiveness, and effectiveness in pain management. As of May 2019, Panag Pharma operates as a subsidiary of Tetra Bio-Pharma Inc.
Laboratoires Holizen
Acquisition in 2016
Laboratoires Holizen produces and distributs high quality NHP and cosmetic products.
Export Hydro
Acquisition in 2015
Export Hydro, a manufacturer and exporter of indoor gardening equipment based in Hong Kong. Export Hydro designs, manufactures, and distributes growing equipment specifically for the medicinal cannabis market. Export Hydro's manufacture direct model allows them to distribute directly to retailers, wholesalers, and commercial producers in North America, Europe, and Australia.
Herbaceous
Funding Round in 2015
Herbaceous Inc. is a Canadian company based in Ontario that specializes in providing personalized medicinal marihuana and special order cannabis strains. The company offers a diverse selection of dried cannabis flowers, each with varying cannabinoid profiles designed to address a range of health conditions. Through its tailored approach, Herbaceous aims to meet the specific therapeutic needs of its customers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.